Literature DB >> 3006461

CT of hepatic masses: significance of prolonged and delayed enhancement.

Y Itai, K Ohtomo, T Kokubo, T Yamauchi, M Minami, N Yashiro, T Araki.   

Abstract

Hepatic masses showing higher density than that of liver after 3 min (prolonged enhancement) and/or having prominent enhancement after the arterial-dominant phase (delayed enhancement) of dynamic CT (bolus enhancement followed by serial scans) were reviewed. Prolonged enhancement was noted in any hepatic masses, but mainly in cavernous hemangioma and capsule of hepatocellular carcinoma, whereas delayed enhancement occurred in capsule of hepatocellular carcinoma and occasionally in metastatic tumor. The volume of arterial and portal blood supply, turnover rate of blood, extent of the interstitial space, and diffusion rate between the vascular and interstitial space, as well as dose and speed of contrast agent administered, seemed to be important factors in such contrast enhancement. Prolonged enhancement and delayed enhancement are nonspecific but still are of some value in the differentiation of hepatic masses on dynamic CT.

Entities:  

Mesh:

Year:  1986        PMID: 3006461     DOI: 10.2214/ajr.146.4.729

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

1.  Capsule and mosaic pattern of hepatocellular carcinoma: correlation between CT and MR imaging.

Authors:  L Lalonde; B Van Beers; J Jamart; J Pringot
Journal:  Gastrointest Radiol       Date:  1992

2.  Delayed enhancement of peripheral zone of neurofibromas at magnetic resonance imaging.

Authors:  Y Kurosaki; K Kuramoto; Y Itai
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Yuichiro Kubo; Shinichi Aishima; Ken Shirabe; Takashi Yoshiura; Hiroshi Honda
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

Review 4.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

5.  The systematic use of operative ultrasound for detection of liver metastases during colorectal surgery.

Authors:  G Boldrini; A M de Gaetano; I Giovannini; M Castagneto; C Colagrande; G Castiglioni
Journal:  World J Surg       Date:  1987-10       Impact factor: 3.352

6.  Differentiation of benign and malignant ampullary obstruction by multi-row detector CT.

Authors:  Wirana Angthong; Kran Jiarakoop; Kaan Tangtiang
Journal:  Jpn J Radiol       Date:  2018-05-21       Impact factor: 2.374

7.  Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Daisuke Okamoto; Nobuhiro Fujita; Takao Ohtsuka; Tomoharu Yoshizumi; Shinichi Aishima; Yoshinao Oda; Hiroshi Honda
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

Review 8.  Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.

Authors:  Byung Ihn Choi; Joon Koo Han; Sung Tae Hong; Kyoung Ho Lee
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity.

Authors:  Maurice H Zissen; Zhen Jane Wang; Judy Yee; Rizwan Aslam; Alexander Monto; Benjamin M Yeh
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

10.  Contribution of CT to characterization of focal nodular hyperplasia of the liver.

Authors:  C Procacci; C Fugazzola; M Cinquino; G Mangiante; L Zonta; I A Andreis; N Nicoli; G F Pistolesi
Journal:  Gastrointest Radiol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.